Filter

Buy 3-MMC Powder (3-Methylmethcathinone)

3-MMC (3-Methylmethcathinone)

Name: 3-MMC (3-Methylmethcathinone)
SKU: 4591
Availability: InStock

Price range: $205.00 through $1,950.00

Quantity

Clear

Description
Additional information

3-MMC (3-Methylmethcathinone): Complete Scientific & Regulatory Overviewy

Buy 3-MMC Powder (3-Methylmethcathinone)! This page provides scientific, educational, and regulatory information only. 3-MMC is a controlled substance under international and national laws. It is not approved for human consumption, medical use, or non-research purposes. This content does not encourage, facilitate, or endorse the unlawful acquisition, possession, or use of any substance. Always verify compliance with local regulations.

Chemical Classification & Properties

3-Methylmethcathinone (3-MMC), also known as metaphedrone, is a synthetic compound belonging to the class of substituted cathinones — a family of β-ketoamphetamine stimulants structurally related to the khat plant alkaloid cathinone. It is a positional isomer of mephedrone (4-MMC), differing only in the methyl group placement on the benzene ring (3-position vs. 4-position).

Property	Specification
IUPAC Name	2-(Methylamino)-1-(3-methylphenyl)propan-1-one
CAS Number	1246911-86-3
Molecular Formula	C₁₁H₁₅NO
Molecular Weight	177.24 g/mol
Chemical Class	Substituted cathinone / synthetic cathinone
Structural Relation	Positional isomer of mephedrone (4-MMC)
Appearance	White crystalline powder

3-MMC is structurally classified within the broader [Synthetic Cathinones] category — a group of research compounds widely studied for their monoamine-modulating properties.

Pharmacological Mechanism of Action

3-MMC functions primarily as a monoamine transporter substrate and releaser — it enters presynaptic neurons via dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporters and causes the release of stored neurotransmitters into the synaptic cleft, while also inhibiting their reuptake, thereby amplifying and prolonging synaptic signaling.

Transporter Selectivity Profile

Research indicates 3-MMC exhibits marked preference for catecholamine transporters over serotonin transporters, distinguishing it from mephedrone (4-MMC), which shows more balanced activity:

Transporter	Potency (IC₅₀ / Inhibition)	Relative Selectivity
Norepinephrine (NET)	Highest potency	100%
Dopamine (DAT)	High potency	98%
Serotonin (SERT)	Moderate potency	50%

Key distinction: 3-MMC is notably more potent at NET and DAT than SERT, producing a profile more similar to classical psychostimulants (amphetamine-like) than the balanced entactogen profile of 4-MMC or MDMA. It also binds to adrenergic receptors (α₁A, α₂A) and certain serotonin receptors (5-HT₁A, 5-HT₂C), but unlike mephedrone, it does not significantly activate 5-HT₂A receptors.

In summary: 3-MMC boosts dopamine and norepinephrine most strongly, with moderate serotonin release — producing stimulant effects with empathogenic components.

Acute Health Risks & Toxicity Profile

Acute Physiological Effects

Sympathomimetic stimulation is the primary driver of adverse effects, which may include:

Cardiovascular: Tachycardia, hypertension, palpitations, chest pain, ECG abnormalities
Neurological: Headache, dizziness, insomnia, bruxism, dilated pupils, tremors, seizures at high doses
Psychiatric: Agitation, anxiety, confusion, paranoia, hallucinations, mood lability
Systemic: Hyperthermia, diaphoresis, nausea, dry mouth, muscle tension, hyponatremia, rhabdomyolysis

Toxicity & Risk Factors

Dose-dependent risks: A human clinical study reported that low-to-moderate doses (25–100 mg) were generally well-tolerated with mild cardiovascular increases, but higher doses substantially elevate risk of cardiovascular and neurological toxicity.
Polysubstance danger: Combining 3-MMC with other serotonergic agents (SSRIs, SNRIs, MDMA, tricyclics) carries a life-threatening risk of serotonin syndrome.
Fatal outcomes: Documented fatalities have occurred, particularly in contexts of high-dose use, intravenous administration, or polysubstance combinations.
Dependence potential: Strong dopaminergic activity creates significant psychological dependence liability; chronic use may produce withdrawal (fatigue, depression, anhedonia).

Research-only context: Even in controlled laboratory settings, 3-MMC requires full awareness of its sympathomimetic toxicity and strict adherence to safety protocols. It is not a benign compound — its potency and cardiovascular profile demand extreme caution.

Legal & Regulatory Status

International Scheduling

United Nations: Placed under Schedule II of the Convention on Psychotropic Substances (1971) effective March 2023, following a WHO critical review.
European Union: Subject to EU-wide control since 2022; banned across member states. Individual implementations vary:
- 🇳🇱 Netherlands: Reclassified from List II to List I (highest risk) in April 2024
- 🇩🇪 Germany: Anlage I — authorized scientific use only
- 🇬🇧 United Kingdom: Class B controlled substance
- 🇸🇪 Sweden: Narcotic classification
- 🇵🇱 Poland: Controlled since April 2024
🇨🇭 Switzerland: Controlled under Verzeichnis E; permitted only for scientific/industrial use
🇨🇦 Canada: Controlled under the CDSA as an analogue
🇨🇳 China: Controlled since October 2015
🇮🇳 India: Designated narcotic February 2024

United States Status

DEA Schedule I: Explicitly designated as a Schedule I controlled substance effective December 13, 2023, due to being a positional isomer of mephedrone and lacking accepted medical use.
Prior to explicit scheduling, it was prosecutable under the Federal Analogue Act.
Several states independently enacted bans.

For researchers: Procurement, possession, and use require appropriate licenses, institutional affiliation, and compliance with both federal and international regulations. Unauthorized possession is a criminal offense in nearly every jurisdiction.

Research Context & Compliance

3-MMC continues to be of interest in analytical chemistry, forensic toxicology, and neuropharmacology — primarily as a reference standard and a tool to structure–activity relationship (SAR) studies. Valid research applications include:

Forensic reference materials — analytical standards for detection method validation
Receptor binding & transporter studies — comparing structure–activity relationships across cathinone analogs
Metabolic & toxicological research — understanding synthetic cathinone metabolism and biomarkers

All legitimate research requires:

Institutional review board (IRB) or ethics committee approval
Valid DEA or equivalent national license
Secure, controlled storage and chain-of-custody documentation
Compliance with import/export permits and customs declarations

For qualified laboratories, related reference standards are available within the [Synthetic Cathinones] category, alongside other regulated [Research Chemicals]. Always consult [About Us] regarding compliance documentation and licensing verification before ordering. Buy 3-MMC Powder (3-Methylmethcathinone) with bitcoin

Frequently Asked Questions

What exactly is 3-MMC, and how does it differ from mephedrone (4-MMC)?

3-MMC (mephedrone) is a synthetic cathinone — a positional isomer of mephedrone. The critical difference is receptor selectivity: 3-MMC acts more strongly on dopamine/norepinephrine transporters (more stimulant-like), whereas 4-MMC has balanced activity across all three transporters (more entactogen-like). Both are controlled substances.

What does “monoamine reuptake inhibition and release” mean?

3-MMC enters nerve terminals via transporter proteins and causes the release of dopamine, norepinephrine, and serotonin into the synaptic cleft, while also blocking their removal. This prolongs and amplifies neurotransmitter signaling — producing stimulant effects. Its strongest effects are on dopamine and norepinephrine.

Is 3-MMC illegal? Can I legally obtain it for personal research?

Yes, it is illegal in most countries. Under UN Schedule II (2023) and national implementations including US DEA Schedule I (Dec 2023), it may be obtained only by properly licensed researchers or institutions with valid permits. Personal possession without authorization is a criminal offense. Buy 3-MMC Powder (3-Methylmethcathinone) with credit card.

What are the most serious known risks?

Cardiovascular strain (tachycardia, hypertension, cardiac risk), hyperthermia, seizures, serotonin syndrome if combined with other serotonergic drugs, psychological dependence, and fatal toxicity at high doses or with polysubstance use. Chronic effects remain understudied.

Where can I find authoritative information on cathinone regulation and health risks?

Consult the UNODC (unodc.org), EMCDDA (eu/emcdda), DEA Diversion Control Division, and WHO chemical risk assessment publications. Always cross-reference with your national drug control agency and local laws.

Internal Linking Reference (as Requested)

Category: Synthetic cathinone research compounds → [Synthetic Cathinones]
Category: Laboratory reference standards → [Research Chemicals]
Product: Related analytical standards → Link to specific product pages when applicable
Compliance & sourcing info → [About Us]
Inventory & availability → [SHOP]

Conclusion: 3-Methylmethcathinone (3-MMC)

3-MMC represents an important case study in synthetic cathinone pharmacology — its distinct transporter selectivity profile reinforces how subtle structural changes dramatically alter biological activity. While scientific interest remains high, its international scheduling as a controlled substance reflects significant public health risks, including cardiovascular toxicity, dependence potential, and fatal outcomes in misuse contexts.

For legitimate researchers, 3-MMC remains available only through authorized channels with full licensing and institutional oversight. Compliance begins with understanding not just the science, but the legal framework governing every aspect of procurement, storage, and use. Always prioritize verified reference materials, ethical research conduct, and strict regulatory adherence.

Final note: This page is maintained for educational and scientific reference only. For the most current legal status, consult your national competent authority and the UNODC International Drug Control Conventions.